The effect of two varying doses of intravenous tranexamic acid on blood loss after vaginal delivery at term in University of Benin Teaching Hospital - Trial PACTR202310814099421
Access comprehensive clinical trial information for PACTR202310814099421 through Pure Global AI's free database. This Not Applicable trial is sponsored by Centre for excellence in reproductive health initiative and is currently Recruitment Completed. The study focuses on Obstetrics and Gynecology.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Centre for excellence in reproductive health initiative
Michael Osahumen Orhue
Timeline & Enrollment
Not Applicable
Jan 01, 1900
Jan 01, 1900
Summary
Primary postpartum haemorrhage is a common cause of maternal mortality especially in third world countries where there is relative lack of blood transfusion services, coupled with the high prevalence of anaemia in pregnancy which makes women in these settings more prone to adverse outcome from PPH. this underscores the need to explore other innovative strategies for the prevention of PPH in addition to the active management of third stage labour recommended by the World Health Organization. Tranexamic acid is currently recommended in the management of PPH. however, its role in the prevention of PPH is still being studied. this study seeks to explore the effect of tranexamic acid on reducing blood loss following vaginal delivery as a surrogate for the prevention of PPH.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202310814099421
Non-Device Trial